Jul 13, 2026 – 5.59pmUniversity of Queensland spin-out Ceretas could be trading on the local bourse as early as next week after its initial public offering fetched strong demand.The medical technology firm, which develops portable ultrasound devices designed to treat brain conditions like Alzheimer’s disease, has sold 32 million shares for 25¢ a piece. This represents an indicative market capitalisation of $18 million.Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones.Kanika Sood is a journalist based in Sydney who writes for the Street Talk column.Emma Rapaport is a co-editor of the Street Talk column. Prior to that, she was a markets reporter at The Australian Financial Review.Angira Bharadwaj is a banking and financial services reporter for The Australian Financial Review. Send tips to @angirab.60 on encrypted messaging platform Signal.Subscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber?